Biological risk assessment and management is our tool to foster the positive impact of the advancement of bioscience and biotechnology for society.

S1 Adapted solutions for
biorisk management

S2 Evaluation of new
techniques and
environmental risk
assessment

S3 Applicable misuse
prevention and
biosecurity

S4 Promotion of global
biosafety and biosecurity

S5 Mentoring of biosafety
and biosecurity
professionals

S6 Public communication
and open-space
biosafety

Us and our partnering network

During our 20 years of business, we have consequently and consistently built and maintained our partnership with experts and partnering networks internationally.

1st ABSA Biosecurity Conference, lessons learnt

April 26 2021
The highly diverse program of the first biosecurity conference of ABSA international highlights past experiences and future prospects in biosecurity

COVID-19 and the UN Sustainable Development Goals

April 19 2021
„Biosafety: gatekeeper for sustainability in biotechnology?“ (https://sdgs.un.org/goals)

Efficacy of COVID-19 vaccines and why they are so difficult to compare

März 10 2021
With a number of COVID-19 vaccines on the market what does it mean if I’m vaccinated by one or the other vaccine?
Go to Blog
«Jenal & Partners with their large knowledge and experience have improved our biosafety procedures significantly not only regarding safety, but also regarding sustainability and economical aspects. Most importantly though, communication, information transfer and review processes with all stakeholders assure consensus building, understanding and voluntary adoption of our biosafety procedures.»
Thomas Moser, Head Health Safety Security & Environment, Idorsia Pharmaceuticals Ltd. Allschwil, Switzerland
«Zusammenarbeit: Dui pellentesque a quis semper nunc accumsan risus gravida adipiscing. Pellentesque ac egestas venenatis massa lobortis nibh interdum.»
Viji Vijayan, MD, Associate Professor, Duke-National University of Singapore Medical School, American Biological Safety Association